Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00503867 · ClinicalTrials.gov registry record · NA
SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma
A NA study, sponsored by Sirtex Medical.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00503867: Clinical Trial NA study, sponsored by Sirtex Medical.
NCT00503867 is a NA study that was terminated before completion, run by Sirtex Medical. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00503867, a NA study, was terminated before completion, sponsored by Sirtex Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The main purpose of this study is to determine the safety and toxicity of treatment with SIR-Spheres® in patients with unresectable primary liver cancer or hepatocellular carcinoma (HCC). Other purposes of this study include assessment of the effect of treatment on overall survival, the length of time it takes for the disease to worsen, if and how the treatment affects the patient's quality of life, and if and how the cancer responds to the treatment.
Primary Outcome
Using the National Cancer Institute Common Terminology Criteria (NCI-CTC) version 3.0 as recorded in the case report form.
Interventions
- DEVICE SIR-Spheres microspheres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-07-18 |
| Est. Completion | 2010-03-09 |
| Phase | NA |
Why NCT00503867 stopped before completion
NCT00503867 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which SIR-Spheres microspheres is the first listed.
NCT00503867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00503867 about?
NCT00503867 is a clinical study titled "SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma". The main purpose of this study is to determine the safety and toxicity of treatment with SIR-Spheres® in patients with unresectable primary liver cancer or hepatocellular carcinoma (HCC). Other purposes of this study include assessment of the effect of treatment on overall survival, the length of ti...
What is the current status of trial NCT00503867?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2007-07-18. Estimated completion is 2010-03-09.
What interventions are being tested in trial NCT00503867?
The interventions under investigation include: SIR-Spheres microspheres (DEVICE).
Who is sponsoring clinical trial NCT00503867?
This trial is sponsored by Sirtex Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00503867's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI